NASDAQ:APOP Cellect Biotechnology - APOP Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cellect Biotechnology Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Add Compare Share Share Today's Range$13.10▼$13.3750-Day Range$7.54▼$13.4052-Week Range$6.64▼$35.52Volume17,400 shsAverage Volume479,845 shsMarket Capitalization$12.87 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Cellect Biotechnology (NASDAQ:APOP) StockCellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.Read More Receive APOP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cellect Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address APOP Stock News HeadlinesNovember 24, 2022 | morningstar.comWhy These Biotech Stocks Are Outperforming the MarketNovember 16, 2022 | realmoney.thestreet.comSeeing Good Action in Biotechnology StocksJanuary 30, 2023 | Porter & Company (Ad)The Next Big Crisis Is HereYou just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.September 18, 2022 | fool.co.ukInvesting in Biotech: Top UK Biotech Stocks in 2022November 4, 2021 | finance.yahoo.comQuoin Pharmaceuticals Appoints Gordon Dunn as Chief Financial OfficerNovember 2, 2021 | finance.yahoo.comQuoin Pharmaceuticals Announces Signing of Exclusive License from Queensland University of Technology, AustraliaOctober 15, 2021 | finance.yahoo.comCellect Biotechnology Announces Record Date and Distribution Date for CVRs in Connection with Strategic Merger with Quoin PharmaceuticalsOctober 14, 2021 | finanznachrichten.deCellect Biotechnology Ltd.: Cellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin PharmaceuticalsJanuary 30, 2023 | Porter & Company (Ad)Is This The End of Capitalism?EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…September 27, 2021 | benzinga.comWhy Cellect Biotechnology Shares Are Rising TodaySeptember 27, 2021 | finance.yahoo.comCellect Biotechnology Announces Shareholder Approval of Strategic Merger with Quoin PharmaceuticalsSeptember 3, 2021 | markets.businessinsider.comPre-market Movers: APOP, FBRX, ANY, AGIL, ADXS…September 2, 2021 | finance.yahoo.comCellect Biotechnology Announces the ApoGraft™ Bone Marrow Transplantation of First Patient in U.S.August 24, 2021 | finance.yahoo.comCellect Biotechnology Reports Second Quarter 2021 Financial and Operating ResultsAugust 13, 2021 | finance.yahoo.comThe Securities and Exchange Commission Declared Cellect Biotechnology’s Registration Statement Filed on Form F-4 Effective in Connection with its Previously Announced Strategic Merger with Quoin PharmaceuticalsJuly 27, 2021 | nasdaq.comCellect Biotechnology Ltd. American Depositary Shares (APOP)June 17, 2021 | baystreet.caCellect Registers Merger AgreementJune 17, 2021 | msn.comWhy Are Cellect Biotechnology (APOP) Shares Surging Today?June 16, 2021 | finance.yahoo.comCellect Biotechnology Files Registration Statement in Connection with Proposed Strategic Merger Agreement with Quoin PharmaceuticalsMay 17, 2021 | finance.yahoo.com/R E P E A T -- Halo Collective Inc. Reports Record First Quarter Results/May 17, 2021 | finance.yahoo.comHalo Collective Inc. Reports Record First Quarter ResultsApril 19, 2021 | finance.yahoo.comCellect Bio's ApoGraft Therapy Is Safe, Tolerable In GvHD StudyApril 19, 2021 | finance.yahoo.comCellect Biotechnology Reports Top Line Data from Phase 1/2 Clinical TrialMarch 29, 2021 | finance.yahoo.comCellect Biotechnology Reports Fourth Quarter and Full Year 2020 Financial and Operating ResultsMarch 26, 2021 | finanznachrichten.deCellect Biotechnology Ltd.: Cellect Biotechnology and Quoin Pharmaceuticals Announce Strategic MergerMarch 25, 2021 | baystreet.caCellect Jumps on Quoin HookupMarch 25, 2021 | msn.comWhy Is It Moving? Looking Into Why Cellect Biotechnology's Stock is Trading Higher TodaySee More Headlines Receive APOP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cellect Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address APOP Company Calendar Last Earnings11/13/2018Today1/29/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & Medical Instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:APOP CUSIPN/A CIK1671502 Webwww.cellect.co Phone(729) 974-1444Fax972-9767-8750Employees2,020Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio3.01 Quick Ratio3.01 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$4.77 per share Price / Book2.76Miscellaneous Outstanding Shares977,000Free FloatN/AMarket Cap$12.87 million OptionableNot Optionable Beta1.87 Key ExecutivesShai YarkoniChief Executive Officer & DirectorAmos OferChief Operating OfficerYaron Ben-OzChief Financial OfficerKey CompetitorsSharps TechnologyNASDAQ:STSSInspira Technologies Oxy B.H.N.NASDAQ:IINNNephrosNASDAQ:NEPHT2 BiosystemsNASDAQ:TTOOFemasysNASDAQ:FEMYView All Competitors APOP Stock - Frequently Asked Questions How were Cellect Biotechnology's earnings last quarter? Cellect Biotechnology Ltd. (NASDAQ:APOP) announced its quarterly earnings data on Tuesday, November, 13th. The company reported ($0.58) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.56) by $0.02. When did Cellect Biotechnology's stock split? Cellect Biotechnology's stock split on the morning of Tuesday, October 26th 2021. The 2-1 split was announced on Tuesday, October 26th 2021. The newly minted shares were payable to shareholders after the market closes on Tuesday, October 26th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. What other stocks do shareholders of Cellect Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cellect Biotechnology investors own include Elbit Systems (ESLT), Gilead Sciences (GILD), Protalix BioTherapeutics (PLX), Pluristem Therapeutics (PSTI), NVIDIA (NVDA), Teva Pharmaceutical Industries (TEVA), Acasti Pharma (ACST), Allergan (AGN), Novavax (NVAX) and RedHill Biopharma (RDHL). What is Cellect Biotechnology's stock symbol? Cellect Biotechnology trades on the NASDAQ under the ticker symbol "APOP." What is Cellect Biotechnology's stock price today? One share of APOP stock can currently be purchased for approximately $13.17. How much money does Cellect Biotechnology make? Cellect Biotechnology (NASDAQ:APOP) has a market capitalization of $12.87 million. How many employees does Cellect Biotechnology have? The company employs 2,020 workers across the globe. How can I contact Cellect Biotechnology? Cellect Biotechnology's mailing address is 23 HATA`AS STREET, KFAR SABA L3, 44425. The official website for the company is www.cellect.co. The company can be reached via phone at (729) 974-1444, via email at ir@cellectbio.com, or via fax at 972-9767-8750. This page (NASDAQ:APOP) was last updated on 1/30/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.